Grant McGaugh
March 11, 2025
Imagine being told by a doctor that nothing more can be done for your child. Would you accept it or fight for every possible chance at life? For Rochelle Prosser, surrender was never an option.
When Rochelle’s four-year-old daughter was diagnosed with stage 4 brain cancer, the prognosis was grim. The healthcare system offered little hope, and the situation grew even more desperate as her husband simultaneously battled cancer. Instead of giving in, Rochelle transformed her anguish into action—standing alone as the fierce advocate her family desperately needed.
Her story is raw and heartbreaking, yet deeply inspiring. It is the tale of a mother, a nurse, and a relentless warrior who refused to let the system decide who gets to live. For anyone who has ever faced the uncertainty of cancer, Rochelle’s journey is a powerful reminder of the importance of fighting for the best possible care.
Rochelle’s transformation from a neurotrauma ICU nurse to a cancer care disruptor is a testament to her resolve. As the founder and CEO of Orchid Healthcare Solutions, she has taken up the mantle to eliminate disparities in cancer treatment and ensure that patient rights are at the forefront of care. Her work bridges the gap between medical innovation and accessible treatment options—especially for those who have historically been underserved.
In a candid discussion on the Follow The Brand Podcast, hosted by Grant McGaugh, Rochelle shared her experiences navigating the complex and often impersonal world of cancer care. Her insights reveal not only the personal cost of fighting a failing system but also the urgent need for change in how oncology care is delivered.
Rochelle’s ordeal began when her husband and young daughter were both diagnosed with cancer—a nightmare that forced her to wear multiple hats: caregiver, medical expert, and advocate. Her daughter’s diagnosis of inoperable stage 4 brain cancer was particularly harrowing. When doctors suggested that the best option was to “make her comfortable at home,” Rochelle challenged them with a simple, heart-wrenching question: “Are you going to treat my child or not?”
The response was not one of support, but of clinical hesitation. The potential treatments had never been tested on African-American children, let alone young girls. Faced with a lack of precedent and uncertain outcomes, Rochelle pushed the system to think outside its rigid protocols, demanding innovative solutions where none seemed to exist.
At the same time, her husband—a commercial truck driver—was battling a dangerous lung tumor. Relying on her extensive medical expertise, Rochelle self-diagnosed his condition before it was even recognized by his physicians. When his doctor attempted to enroll him in a clinical trial with a treatment that carried outdated and deadly risks, Rochelle intervened at the very moment a critical, irreversible decision was about to be made.
Through her personal and professional experiences, Rochelle has pinpointed what she calls the “Three Fundamental Barriers to Oncology Treatment”:
Rochelle explains, “If you change just one of these barriers, the outcome shifts. Any one of them could mean the difference between life and death.”
ut of this turbulent journey, Orchid Healthcare Solutions was born—a platform designed to empower patients with expert navigation, advocacy, and technology-driven resources. The organization provides:
Rochelle Prosser is a dedicated Army Mom, healthcare founder, and patient advocate who has turned her personal battles into a mission to transform cancer care. With a rich background as a neurotrauma critical care nurse and a Certified Legal Nurse Consultant, she has created the Prosser Cancer Treatment Library—a comprehensive resource aimed at bridging information gaps and easing the journey for families facing cancer.
Her leadership and advocacy have made her an influential voice in the fight for equitable healthcare, particularly for African-American communities. Rochelle’s involvement spans multiple prestigious organizations and boards, underscoring her commitment to reshaping the future of oncology.